Nov 06, 2017 12:30 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., Nov. 06, 2017 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...
Noble Energy to Present at Upcoming Energy Conference
Nov 06, 2017 12:30 pm UTC| Business
Houston, Nov. 06, 2017 -- Noble Energy, Inc. (NYSE: NBL) announced today that Gary W. Willingham, the Company’s Executive Vice President of Operations, will present at the Bank of America Merrill Lynch Global Energy...
Nov 06, 2017 12:20 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., Nov. 06, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm engaged in the development of...
Nov 06, 2017 12:05 pm UTC| Business
BALTIMORE and SALT LAKE CITY, Nov. 06, 2017 -- CareFirst BlueCross BlueShield (CareFirst) and Myriad Genetics, Inc. (NASDAQ:MYGN), a global leader in molecular diagnostics and personalized medicine, today announced that...
Nov 06, 2017 12:01 pm UTC| Business
Tel Aviv Sourasky Medical Center will act as the sponsor of the studyPLX-PAD cells have demonstrated efficacy in preclinical models of GvHD HAIFA, Israel, Nov. 06, 2017 -- Pluristem Therapeutics Inc....
Nov 06, 2017 12:01 pm UTC| Business
TORONTO, Nov. 06, 2017 -- IC Potash Corp. (TSX:ICP) (OTCQB:ICPTF) (“IC Potash” or the “Company”) is pleased to announce that the business development strategy of ICP Organics, a wholly owned subsidiary of the Company,...
Edge Therapeutics to Present at the 26th Annual Credit Suisse Healthcare Conference
Nov 06, 2017 12:01 pm UTC| Business
BERKELEY HEIGHTS, N.J., Nov. 06, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions,...